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Abstract.  We examined the effects of thrombospondin 
(TSP)  in the substrate adhesion of bovine aortic en- 
dothelial cells. The protein was tested both as a sub- 
strate for cell adhesion and as a modulator of the later 
stages  of the cell adhesive process.  TSP substrates 
supported the attachment of some BAE cells, but not 
cell spreading or the formation of focal adhesion 
plaques.  In contrast, cells seeded on fibrinogen or 
fibronectin substrates were able to complete the adhe- 
sive process, as indicated by the formation of focal 
adhesion plaques. Incubation of cells in suspension 
with soluble TSP before or at the time of seeding onto 
fibronectin substrates resulted in an inhibition of focal 
adhesion formation. Furthermore, the addition of TSP 
to fully adherent cells in situ or prespread on fibronec- 
tin substrates caused a reduction in the number of 
cells, which were positive for focal adhesions, al- 
though there was no significant effect on cell spread- 
ing.  In a dose-dependent manner, TSP reduced the 
number of cells with adhesion plaques to ,,o60%  of 
control levels.  The distribution of remaining adhesion 
plaques in TSP-treated  cells was also altered: plaques 
were primarily limited to the periphery of cells and 
were not present in the central cell body, as in control 
cells treated with BSA.  The observed effects were 
specific for TSP and were not observed with platelet 
factor 4, beta-thromboglobulin, or fibronectin. The 
TSP-mediated loss of adhesion plaques was neutralized 
by the addition of heparin, fucoidan, other heparin- 
binding proteins, and by a monoclonal antibody to the 
heparin binding domain of TSP, but not by antibodies 
to the core or carboxy-terminal regions of TSP. The 
interaction of the heparin-binding domain of TSP with 
cell-associated heparan sulfate appears to be an impor- 
tant mechanistic component for this activity of TSP. 
These data indicate that TSP may have a role in 
destabilizing cell adhesion through prevention of focal 
adhesion formation and by loss of preformed focal 
adhesions. 
T  ri~. growth of anchorage-dependent cells is dependent 
on the ability of these cells to interact with a substrate 
which promotes physiological cell adhesion.  Studies 
of in vitro model systems show that physiological cell sub- 
stratum adhesion is a multistep process composed of several 
discrete stages (reviewed in references 3, 53). When a sus- 
pension of cells is seeded on a suitable substrate, the cells 
will initially attach to the substrate: if the substrate is com- 
posed  of physiological adhesion  molecules,  attached cells 
will then proceed to flatten and spread with subsequent orga- 
nization of specialized regions of the membrane and cyto- 
skeleton into mature adhesion contacts, e.g., focal adhesion 
plaques. These plaques are involved in stabilizing cell sub- 
strate contacts. In recent studies, the molecular mechanisms 
involved in the adhesive process have begun to be elucidated. 
A family of receptors,  the integrins,  binds  primarily to a 
RGD-containing sequence present in adhesive proteins. The 
interaction of integrins with substrate molecules appears to 
be required for cell attachment and spreading (reviewed in 
references  3,  16,  43,  45).  Subsequent  formation  of focal 
adhesions requires an additional interaction between a cell 
associated heparan sulfate proteoglycan (50, 51) and a gly- 
cosaminoglycan binding site in the substrate molecule (26, 
42, 52). 
The process of physiological adhesion is dynamic and ap- 
pears to be highly regulated.  Focal adhesion plaques must 
disassemble during mitosis and when cells become motile 
and then re-form when ceils return to the stationary state (3, 
6, 53). Adhesion plaques are generally absent or reduced in 
highly migratory  cells,  whereas,  they are abundant in sta- 
tionary  anchorage-dependent  cells  (6). Similarly,  trans- 
formed cells, which generally are more motile, have fewer 
and smaller focal adhesions than their nontransformed coun- 
terparts (3, 31). It is unclear how the assembly and disassem- 
bly of focal adhesion plaques are regulated. Growth factors, 
phorbol esters, proteases, and agents which increase cAMP 
levels have been implicated in focal adhesion disassembly (2, 
3,  14,  15, 44). 
Thrombospondin  (TSP)  ~ is a trimeric extracellular  ma- 
trix glycoprotein which binds to cells through membrane- 
associated heparan sulfate proteoglycans (18, 35, 36, 41, 46). 
TSP contains a glycosaminoglycan-binding site and also a 
single RGDA sequence in each of three polypeptide chains 
(24). The RGD sequence in TSP has recently been shown to 
1. Abbreviations used in this paper: BAE, bovine aortic endothelial; TSP, 
thrombospondin; PF4, platelet factor 4. 
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(25). The ability of TSP to mediate cell attachment has been 
the subject of numerous studies (reviewed in references 12, 
23) and there are several reports describing TSP-mediated at- 
tachment and spreading of transformed and undifferentiated 
cells  (18, 39,  40,  48,  49).  Data  from several laboratories 
using  different cell types  suggest  that both  integrins  and 
heparan sulfate proteoglycans can mediate initial cell attach- 
ment to TSP substrates  (18, 25) and that sulfated glycolipids 
may be important for melanoma cell spreading  on TSP (41). 
However, there are conflicting data as to whether TSP sup- 
ports  attachment  and  spreading  of  anchorage-dependent 
cells, such as endothelial and smooth muscle cells (5, 19, 20, 
25, 34, 47). One report shows that these cells harvested with 
EDTA will attach to substrates coated with high concentra- 
tions of TSP (47), whereas, other investigators showed that 
trypsin-treated endothelial cells do not attach to substrates of 
TSP isolated from either human platelets or endothelial cell 
cultures (5). In addition, Murphy-Ullrich and Mosher (34) 
reported that TSE either prebound to cells or preincubated 
with substrates, interfered with the ability of bovine aortic 
endothelial (BAE) cells to attach to plastic substrates coated 
with either type V  collagen or fibronectin. This was also 
demonstrated by I_ahav using TSP bound to fibronectin and 
glass substrates (19, 20). 
In  view  of these  apparently  contradictory  results,  we 
decided to investigate the role of TSP in the later stages of 
substrate adhesion of BAE cells. In this study, we examined 
the ability of TSP to serve as a substrate for cell adhesion and 
the effect of TSP on the later stages of the cell adhesion pro- 
cess when the cells are attached to physiological substrates. 
Furthermore, we also studied the effects of  TSP on these later 
stages of the adhesion process (spreading and extent and dis- 
tribution of focal adhesions) in established cultures of BAE 
cells. 
Materials and Methods 
Materials 
The following items were purchased: DME (Celi-Gro, Mediatech, Hem- 
don, VA); FBS (HyClone Laboratories, Logan, UT); 500 #g/ml trypsin-2.2 
mM EDTA (Flow Laboratories, McLean, VA); BSA, chondroitin sulfate 
(shark  cartilage,  mixed  isomers),  fucoidan,  heparin  (porcine intestinal 
mucosa), p-nitropbenoI-N-acetyl-beta-o-glucosamide (N9376),  cyclohexi- 
mide, and glutaraldehyde, (Sigma Chemical Co., St. Louis, MO). Low mo- 
lecular weight heparin (3,000 mol wt) was obtained from Boebringer Mann- 
helm Biochemicals (Indianapolis, IN). Monoclonal anti-vinculin antibody 
(clone VIN-II-5) was purchased from ICN Biocbemicals (Lisle, ILL and 
NBD-pballicidin from Molecular Probes, Inc. (Eugene, OR). Rhodamine- 
labeled goat anti-mouse immunoglobulin antibody and normal mouse as- 
cites control IgG were obtained from Cappel Laboratories (Malvern, PA). 
Monoclonal antibodies to specific domains of TSP were generous gifts of 
Dr. Vishva Dixit, University of Michigan (9-11,  13). In all procedures, heat 
denatured (80°C,  10 min, filtered) BSA was used. 
TSP and Other Proteins 
TSP,  platelet factor 4  (PF4),  beta-thromboglobulin, and  human plasma 
fibronectin were generous girls of Dr. Deane Mosher (University of Wis- 
consin, Madison).  These proteins were purified according to previously 
published methods (32, 33, 35). Human fibrinogen from KABI-Vitrium AB 
(Stockholm, Sweden) was a  gift of Dr.  Lech Switalski,  Department of 
Microbiology, University of Alabama at Birmingham. Contaminating fibro- 
nectin was removed from the fibrinogen by passing the protein solution 
through a column of gelatin-Sepharose. All proteins were pure as assessed 
by SDS-PAGE. 
Cells 
BAE cells (normal strain) were previously characterized (35). Ceils were 
maintained in DME with 4.5 g glucose/liter, 2  mM glutamine, and sup- 
plemented with 20%  FBS. Cultures were passed with trypsin-EDTA and 
used between passages 7  and  12.  Testing for mycoplasma was routinely 
done and all cultures were negative. 
Attachment Assays 
Attachment assays were based on a method described by Lindgren (27) in 
which the number of cells attached to a substrate is determined by measur- 
ing the hexosaminidase activity of cells in a colorimetric reaction. Initial 
assays showed that the enzymatic response is linear in the range of 103-105 
cells. Flat-bottom 96-well (model No. 3596; Costar Data Packaging Corp., 
Cambridge, MA) plates were coated with 100-#1 solutions of  the attachment 
proteins by incubating overnight at 4°C in a humidity chamber. Plates were 
rinsed twice with 0.01 M phosphate buffer, pH 7.4, 0.15 M NaCI,  1 mM 
calcium chloride, 0.5 mM magnesium chloride (PBS+). Additional protein 
binding sites were blocked by incubating the wells for 30 rain with 1% heat- 
denatured BSA in PBS+, followed by two rinses with PBS+. Cells to be 
used in the assay were harvested by treating the cell layers with trypsin- 
EDTA. When cells had detached, soybean trypsin inhibitor at a fivefold ex- 
cess (wt/wt) was added, cells were then centrifuged (200 g), and resus- 
pended in DME containing 0.1% BSA to a concentration of 0.4-6.0  x  105 
cells/ml. Approximately 20 rain elapsed between addition of soybean tryp- 
sin inhibitor and addition of 100 #1 of cell suspensions to substrate-coated 
wells. Cells were then incubated with the substrates for 1 h at 37°C with 
5% CO2.  Unbound cells were removed by washing three times with DME 
containing 0.1% BSA and once with PBS+. Plates were then incubated for 
5 h at 37°C, with 60 #l/well of 5 mM p-nitrophenoI-N-acetyl-beta-a-glucos- 
amide in 0.5 M citrate buffer, pH 5.0, containing 0.25% Triton X-100. Color 
was developed by addition of 90 #1/well of 5 mM EDTA, 0.05 M glycine, 
pH 10.4, and read using a muitiscan ELISA reader (Titertek, Elfab Dy, Fin- 
land) equipped with a 405-aM filter. Each sample was assayed in triplicate 
and experiments were performed at least twice, 
Analysis of Cell Spreading and Focal 
Adhesion Formation 
Cell spreading was assayed essentially as described by Woods et al. (52). 
Glass coverslips (12-mm-diam) were incubated with 100 #1 of a protein so- 
lution containing fibronectin, fibrinogen, TSP, or heat-denatured BSA at a 
concentration of 100 #g/ml or PF4 and beta-thromboglobulin at 800 #g/ml 
and the slides were allowed to dry overnight or maintained in a humidity 
chamber at room temperature. Dried substrates were rehydrated by incuba- 
tion with distilled water (100/zl  for 30 min), followed by three  15-rain 
washes with DME. Coverslips were placed in 24-well plates and additional 
protein-binding sites were blocked by incubating wells at room temperature 
for 30 rain with 0.1% BSA in DME. Wells were washed three times with 
DME. Before harvesting with trypsin-EDTA, 75-mm  2 flasks of subeonflu- 
ent BAE cells were treated for 2 h with 15 #g/ml cycloheximide. After har- 
vesting, cells were treated with excess soybean trypsin inhibitor, centri- 
fuged, and  resuspended to  '~1  ×  105 cells/ml in  DME  with  15  #g/ml 
cycloheximide. This concentration of cycloheximide is sufficient to prevent 
95 % of protein synthesis by BAE cells (Dr. Richard LeBaron, Department 
of Biology,  University of Alabama at Birmingham, unpublished results). 
400-500 #1 of cell suspensions were added to each coverslip per well and 
cells were allowed to attach and spread at 370C, 5% CO2 for 3 or 4 h. For 
viewing by interference reflection or phase microscopy, cells were fixed 
with 3% glutaraldehyde in DME (30 rain, 37°C), rinsed three times with 
DME, and mounted on glass slides with PBS. In some experiments, me- 
dium was removed after the initial 3-4-h incubation, and cells were further 
incubated for up to 4 h with 400 #1/well of  protein solution (TSP, BSA, PF4, 
or beta-thromboglobulin) in DME  with  15 #g/ml cycloheximide. Alter- 
nately, cells and protein solutions were added together at the time of seeding 
on fibronectin-coated coverslips and incubated for 4 h at 37°C. In some ex- 
periments, cells were seeded on glass coverslips, grown overnight in DME 
with 20%  FBS, treated for 2  h  with  15  #g/ml cycloheximide, and then 
washed three times with DME before addition of proteins as described 
above. Cycloheximide-treated cells (106) were also incubated with TSP in 
suspension as previously described (35), washed three times with DME, 
and then seeded onto fibronectin-coated coverslips in the continued pres- 
ence of cycloheximide and monitored for focal adhesions by interference 
reflection microscopy. 
Spread cell area was determined after a 3-h incubation of  cells on various 
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spreading. Cells were viewed by phase microscopy using a Nikon Optiphot 
microscope equipped with a drawing device and a digital planimeter system  o 
(Microplan lI; Laboratory Computer Systems, Inc. Cambridge, MA). 
Interference reflection microscopy using a Nikon Optiphot system was 
used to visualize focal adhesion plaques (17). To quantify the percent of  cells  i 
having focal adhesions, a minimum of 100 spread cells per slide was exam- 
ined. For a cell to be scored as positive, it had to have a minimum of three 
adhesion plaques present either in the central and/or peripheral regions of 
the cell. Spread cells were designated as cells having a nucleus recognizable 
4.0 
by interference reflection microscopy or a noncircular shape.  < 
¢.)  Fluorescence Staining 
Cells were treated as described above, except that cells were fixed with 3% 
formaldehyde in PBS for 10 rain at 37°C, followed by three washes with 
DME. Cells were permeabilized by treatment with 0.1% Triton X-100 in 
PBS+ for 3 rain at 4°C, washed three times with PBS+, followed by three 
5-rain rinses with 50 mM ammonium chloride, pH 7.3. Coverslips were 
washed twice with PBS+ before incubation with 0.1% BSA in PBS+  for 
30 rain to block sites of nonspecific binding. Coverslips were then incubated 
for 60 min with 100 ttl of monoclonal anti-vinculin at a  1:10 dilution, fol- 
lowed by three washes with PBS+, and a 30-rain incubation with rhodaminc 
goat anti-mouse immunoglobulin used at "°50/tg/nd. After washing three 
times with PBS+, these cells were then stained for F actin using 1 U of 
NBD-phallicidin per coverslip for 20 rain at room temperature. Coverslips 
were briefly washed three times with PBS+ before mounting on slides with 
PBS+. Double-labeled slides were viewed using a Nikon Optiphot micro- 
scope equipped with epifluorescence illumination. Normal mouse ascites 
IgG (10/~g/ml) was used as a negative control. 
Results 
TSP as a Substrate for Cell Attachment 
TSP was tested for its ability to mediate attachment of BAE 
cells relative to substrates composed of fibronectin or fibrin- 
ogen,  which are known to support BAE adhesion (7,  8). 
Attachment of  cells to all of  the substrates at 37°C was a time- 
dependent process, which was complete within 1 h (data not 
shown). Cell attachment to either TSP, fibronectin, or fibrin- 
ogen was proportional to the concentration of protein used 
to coat the wells (Fig.  1)  up to coating concentrations of 
3 #g/ml (0.3 pg/well): the number of cells attached did not 
increase when higher concentrations of these proteins were 
used to coat plates. The maximum number of cells attached 
to TSP substrates was 45 % of the number of cells seeded, 
whereas a maximum of 90% of added cells attached to fibro- 
nectin or fibrinogen substrates.  Less than  10%  of seeded 
cells attached to BSA-coated wells (Fig. 1). Thus, while TSP 
supports attachment of BAE cells, it is not as effective as ei- 
ther fibronectin or fibrinogen substrates. 
TSP Substrates Do Not Support BAE Spreading and 
Focal Adhesion Formation 
The ability of BAE cells to spread on substrates of TSP rela- 
tive to other substrates known to support BAE cell spreading 
was examined. BAE cells attached to coverslips coated with 
either 10 ~tg of fibronectin or fibrinogen underwent extensive 
spreading during a  3-h incubation period (Table I). These 
cells were characterized by the presence of focal adhesion 
plaques in 72-79% of the cells (Table I). The plaques were 
distributed throughout the cell body (Fig. 2, a and c). Stain- 
ing  for  vinculin  in  cells  spread  on  fibronectin similarly 
showed that vinculin was clustered into plaques which were 
present both over the central cell body and at the edges of 
0.1 
0.05 
o.o=  o.~  i.o  io 
~g Substrate Added/Well 
l~gure L Attachment of endothelial cells to TSP substrates relative 
to fibronectin and fibrinogen substrates. Attachment assays were 
performed  as described  in Materials and  Methods.  Wells were 
coated with increasing concentrations of either fibronectin (e), 
fibrinogen (A), TSP (D), or BSA (I). 2.2 ×  104 cells were added 
to each well and allowed to attach for 1 h at 37°C. The product of 
enzymatic activity was monitored at an absorbance at 405 nM and 
was proportional to the number of  cells which remained bound after 
washings.  Maximal attachment  to fibronectin-coated wells was 
90% of the cells added (2.0 ×  104 cells/well). In this assay, sam- 
ples were assayed in duplicate on fibrinogen and BSA substrates and 
in triplicate on fibronecfin and TSP substrates. Results are ex- 
pressed as the means of replicate determinations. Standard devia- 
tions are given for samples performed in triplicate. 
the cells (Fig. 3 a). Prominent stress fibers staining for F ac- 
tin were present and traversed the cell body (Fig.  3 b). In 
contrast, cells did not spread well on TSP substrates: the area 
of cells attached to TSP was comparable to that of the few 
cells attached to BSA-coated coverslips (Table I) and there 
was almost no formation of focal adhesions or organization 
of vinculin into plaques (Figs. 2 d and 3 c). Staining for F 
actin in cells attached to TSP substrates showed that the actin- 
containing fibers were sparse, were primarily distributed cir- 
cumferentially in cells, and did not appear to terminate end- 
on at the membrane (Fig. 3 d).  Similarly, most cells were 
not fully spread on coverslips coated with other platelet gly- 
coproteins, such as PF4 or beta-thromboglobulin, even when 
increased (80/zg) amounts of protein were used to coat cov- 
erslips (Table I). Interference reflection images of cells at- 
tached to either PF4 (Fig. 2 b), beta-thromboglobulin (data 
not shown),  or the heparin-binding domain of fibronectin 
(52) resembled those of cells attached to TSP (Fig.  2 d). 
These cells developed close contacts that appeared as broad, 
gray areas by interference reflection microscopy (3, 21, 22). 
To examine the possibility that drying of TSP or other 
heparin-binding proteins during the coating procedure al- 
tered the adhesive properties of  the substrates, cell spreading 
experiments were repeated using coverslips coated with hy- 
drated proteins. Cell spreading and focal adhesion formation 
was slightly enhanced on hydrated TSP or PF4 substrates as 
compared to adsorbed and dried substrates (Table I). How- 
ever, these hydrated substrates were still much less effective 
in promoting spreading and focal adhesion formation than 
were fibronectin substrates. 
TSP Inhibits the Formation of  Focal Adhesions in Cells 
Seeded on F~bronectin Substrates 
Incubation of cells in suspension with TSP at the time of 
Murphy-Ullrich and H66k  Thrombospondin  Effect on Cytoskeleton  1311 Table L Effect of  Sabstrate on Cell Spreading 
Cells with 
Substrate  Cell area*  Cells spread~  focal adhesions§ 
/~m  2  %  % 
Adsorbed 
Fibrinogen  1,155  +  599 (50)  991  72 (150) 
Fibronectin  1,215  +  552 (50)  96H  79 (150) 
PF4  467  :t: 249 (50)  30  <1  (50) 
Beta-thromboglobulin  363  +  152 (20)  20  <1  (20) 
Thrombospondin  328  :t:  170 (101)  12  <1  (150) 
Albumin  261  +  119 (10)  10  <1  (10) 
Hydrated 
Fibronectin  1,335  +  659 (100)  94H  63 (100) 
Thrombospondin  475  +  231  (100)  13  13  (100) 
PF4  660 +  321  (50)  16  17 (100) 
* Cells were seeded in the pre~nce of cycloheximide on coverslips adsorbed with the indicated substrates. After 3 h incubation, attached cells were fixed and 
spread cell area was measured using phase microscopy and a digital planimeter. Results are expressed as the mean cell area +  1 SD. The number of cells counted 
are indicated in the parentheses. 
~; Cells with areas greater than the mean area of cells spread on flbronectin substrates minus one standard are considered to be spread. The minimal area of a 
cell spread on adsorbed substrates is 560 t~m  2 and the minimal area on hydrated substrates is 690/tm  2. 
0 Focal adhesions were detected by interference reflection microscopy. Numbers in parentheses indicate the number of cells counted. 
U  These values are significantly different from thrombospondin values (P < 0.005). 
Figure 2. Cells attached to TSP do not form focal adhesion plaques. Cells attached and spread for 3 h in the presence of 15 ~tg/ml cyclohexi- 
mide on coverslips adsorbed with 20/~g fibrinogen (a), 80/tg PF4 (b),  10 ~tg fibronectin (c), or  10 t~g TSP (d).  Cells were fixed and 
examined by interference reflection microscopy. Focal adhesions are present as dark streaks (arrows)  in cells spread on either fibronectin 
or fibrinogen substrates, but are absent in cells spread on TSP or PF4. Cells spread on TSP and PF4 are slightly contracted and have broad 
lamellae with occasional gray areas of close contacts (arrowheads). Bars,  10 ~m. 
The Journal of Cell Biology, Volume 109, 1989  1312 Figure 3. Localization of actin and vinculin in cells attached to fibronectin and TSP substrates. Cells were incubated for 4 h in the presence 
of 15 #g/ml cycloheximide on coverslips adsorbed with either l0 #g fibronectin (a and b) or 10 #g TSP (c and d). Coverslips were then 
fixed, permeabilized,  and double-labeled  by indirect immunofluorescence using a monoclonal antibody to vinculin and rhodamine-con- 
jugated goat anti-mouse IgG (a and c) and by NBD-phallicidin  binding to F actin (b and d). Cells spread on fibronectin contain plaque 
structures that stain for vinculin (a) and abundant stress fibers that stain for F actin (b). In contrast,  cells attached to TSP generally show 
a diffuse staining of vinculin (c) and sparse actin-containing fibers are limited to circumferential regions of the cell (d). There is no positive 
staining in control  slides in which normal mouse ascites IgG was substituted for the primary antibody  (not shown). Bars,  10 #m. 
seeding resulted in a slight reduction (,020%) of the number 
of cells  attaching  to  a  fibronectin  substrate  (34;  data  not 
shown). For the majority of cells that did attach, there were 
no apparent differences in the degree of spreading observed 
between cells pretreated with TSP and control cells treated 
with BSA (data not shown). 
The number of cells forming focal adhesions on fibronec- 
tin  substrates  when  seeded  in  the  presence  of  TSP  was 
greatly reduced as compared to control cells when examined 
by interference reflection microscopy (Table II). Cells were 
scored as positive or negative for focal adhesions according 
to the criteria described in Materials and Methods. The effect 
of TSP was dose-dependent with a  maximum reduction of 
nearly 50%  in the numbers of focal adhesion positive cells 
as compared to cells seeded  in the presence of BSA,  The 
half-maximal effect was observed at ,02-4 nM (1-2 #g/ml) 
TSP. Preincubation of cells with TSP before seeding also re- 
duced the ability of cells to form focal adhesions.  In these 
assays, cells were incubated in suspension with TSP for 1 h 
at 37 or 4°C, washed, resuspended, and allowed to attach and 
spread on fibronectin substrates for 2 h (Table II). These re- 
sults demonstrate that TSP affects the later stage ofceU adhe- 
sion,  e.g.,  focal adhesion  formation during the process of 
adhesion to fibronectin substrates. 
Treatment with TSP Causes a Loss of Focal Adhesions 
in Spread Cells 
The possibility that TSP could affect not only the assembly 
of focal adhesions during the adhesion process but also the 
stability of preformed focal adhesions in fully spread cells 
was investigated.  TSP was added to cells that had been al- 
lowed  to  attach,  spread,  and  organize  focal adhesions  on 
fibronectin substrates during a  3-4-h period.  TSP was in- 
cubated with these spread cells for 4  h  and then examined 
by interference reflection microscopy for the presence of fo- 
cal adhesion plaques. Results showed that there was a reduc- 
tion in the number of TSP-treated cells having focal adhesion 
plaques which was dependent on the concentration of TSP 
added to the cells (Table III). Data collected from experi- 
Murphy-Ullrich and H66k Thrornbospondin Effect on Cytoskeleton  1313 Table IL Effect of TSP on the Formation of 
Focal Adhesions 
A. Focal adhesions in ceils incubated with TSP during attachment and spreading 
Percent 
TSP  of control 
~g/weH 
0.1  92 
1  75 
3  63 
10  63 
30  62 
100  54 
B.  Focal adhesions in cells preincubated with TSP before  seeding 
Percent 
Ligand  of control 
BSA  100 
TSP (20 tLg)  56 
Heparin (1 ~g)  100 
Heparin and TSP  91 
(A) 65%  of control cells incubated  with 30 ~g BSA on fibronectin  substrates 
formed focal adhesions.  Results  are expressed as percent of  controls that contain 
focal adhesion plaques.  A minimum of 100 cells were examined per condition. 
Coverslips were adsorbed with 10 t~g FN.  Increasing concentrations of TSP 
were added at the time cells, were seeded onto coverslips, and the cells were 
then incubated  for 4 h at 37"C. 
(B) Results are expressed as percent of control cells which were incubated with 
30 #g BSA for 4 h at 37°C, washed, seeded on fibronectin-coated  coverslips 
for 2 h at 37"C, and then examined for focal adhesion formation. 66% of control 
cells formed  focal adhesions. 
ments (n  =  9) performed over several months showed that 
the percentage of cells with focal adhesions was reduced to 
63 %  +  9  SD of BSA-treated control cells.  The maximal 
reduction observed was to 45 % of control cells incubated 
with BSA. TSP at 10-100 #g/well was sufficient to cause a 
nearly maximal loss of focal adhesions in this system. Given 
that  the  number  of controls positive  for  focal  adhesions 
ranged from •65-79%  of the total spread cells, this means 
that the actual percent of focal adhesion positive TSP-treated 
cells ranged from ,x,32--45 % of the total spread cells. The ex- 
tent  and  dose  response  of TSP-mediated  focal  adhesion 
reductive activity were similar to the dose response obtained 
in assays testing the ability of TSP to prevent adhesion plaque 
formation. 
In addition to reducing focal adhesions in cells spread on 
fibronectin, TSP also caused a dose dependent loss of focal 
adhesion plaques in cells in situ (Fig. 4).  BAE cells were 
grown on glass  coverslips in  DME  with  20%  FBS  until 
nearly confluent. Cycloheximide was added and cells were 
then exposed to increasing concentrations of TSP for 4  h 
(Fig. 4). The number of cells with focal adhesions was re- 
duced in TSP-treated cultures (100 #g TSP) in a dose depen- 
dent manner to a maximum of  nearly 50% of  control cultures 
which were treated with cycloheximide and BSA. In eight 
separate experiments in which cells were exposed to 30 #g 
TSP, the average percent of focal adhesion positive cells rela- 
tive to BSA-treated controls was 60  5:5 %. 
Although TSP-treatment caused a reduction in the number 
of cells that were positive for focal adhesions, there were no 
significant differences in either the percent of cells spread or 
in the area of spread cells. In 10 separate experiments using 
cells spread on fibronectin substrates, the percent of spread 
cells in TSP-treated samples was  93  +  11%  of the BSA- 
treated controls. Similar results were obtained from experi- 
ments using cells in situ. The spread cell areas of  TSP-treated 
cells were similar (95 % of control areas) to control cells. 
However, rare preparations of TSP did cause a reduction in 
cell spreading to 80% of controls, along with a more com- 
plete loss of focal adhesions to ,x,22 % of controls. 
Interference reflection microscopy of TSP-treated ceils 
spread on fibronectin substrates showed that in the cells that 
still had focal adhesions,  the plaques that remained were 
generally fewer, shorter, and lighter gray in intensity (Fig. 
5 b).  The remaining plaques were primarily located at the 
cell edges with few, if any, focal adhesions located in the cen- 
tral portion of  the cells (Fig. 5 b): this characteristic distribu- 
tion was also observed in TSP-treated cells in situ. In con- 
trast, control cells either seeded on fibronectin substrates or 
spread on native matrices in situ and incubated with BSA 
characteristically had adhesion plaques distributed in both 
central and peripheral regions of the cell (Fig. 5 a). The dis- 
tribution and intensity of vinculin staining in TSP-treated, as 
well as, BSA control cells correlated with their respective in- 
terference reflection images (Fig. 6). In BSA-treated cells, 
vinculin plaques were abundant and were present both in the 
central cell body and at the cell edges (Fig. 6 c), whereas, 
in TSP-treated ceils, vinculin staining plaques were sparse, 
thin, and primarily restricted to the cell edges (Fig. 6 d). 
Staining for F actin in TSP-treated cells demonstrated a cor- 
responding tendency of actin microfilaments to be located 
primarily at the periphery of cells (Pig. 6f), in contrast to 
the thicker stress-fibers which traversed the entire cell in 
BSA-treated controls (Fig. 6 e). Phase microscopy of spread 
cells (Fig. 6, a and b) incubated with TSP showed that these 
cells were more often somewhat spindle-shaped, had polar- 
ity, and frequently had broad cytoplasmic processes (Fig. 6 b). 
The reduction in focal adhesions due to addition of TSP 
appeared to be complete within 60 min of incubation, al- 
Table IlL Effect of TSP on Loss of  Focal Adhesions in 
Spread Cells 
Added  Percent 
protein  of controls 
Thrombospondin 
~g/weH 
0.1  100 
1  81 
3  79 
10  65 
30  65 
100  62 
PF4  1  99 
10  105 
30  97 
Fibronectin  30  124 
Beta-thromboglobulin  30  91 
Results are expressed as percent of control cells with focal adhesions.  Control 
cells were incubated with 30 ~ag BSA and the mean number of control cells with 
focal adhesions was 74%. A minimum of 100 cells were examined per condi- 
tion.  TSP or other proteins were added to cells seeded on substrates of 10 p.g 
adsorbed fibronectin and allowed to spread for 3-4 h. Added proteins were in- 
cubated with cells for 4 h before  fixation  and  microscopic examination. 
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,_  ,  Figure 4. Treatment  with TSP 
results  in  a  dose-dependent 
reduction  of  focal  adhesion 
plaques in cells  in situ.  Cells 
grown  on  coverslips  were 
•  treated  with  increasing  con- 
centrations ofTSP (e) or plate- 
let factor 4 (4) for 4 h before 
fixation and examination by in- 
terference  reflection  micros- 
copy. Control cells were trealed 
,  ,  ,  with  30  pg  BSA  in  500  #1 
o.,  ,  )  o  ,  oo  DME (o). A minimum of 100 
,g Add.~/w.,,  spread cells per coverslip  was 
examined  to  determine  the 
presence of focal adhesion plaques.  Results  are expressed as the 
percent of cells with focal adhesions as compared to BSA treated 
control  cells.  86%  of BSA-treated  controls  had  focal adhesion 
plaques.  Cells incubated  with either 30 #g fibronectin  or  10 #g 
beta-thromboglobulin had 97 % and 99%, respectively,  of control 
levels of focal adhesions (not shown). All cells were pretreated  with 
15 #g/ml cycloheximide  for 2 h before addition of proteins and fur- 
ther incubations  were in the presence of cycloheximide. 
though a slight further reduction was observed at 4 h of incu- 
bation with TSP (data not shown). It was previously shown 
that maximal binding of TSP to BAE cells occurred by 60 
min of incubation at 37°C (35). 
The reduction of focal adhesions was not due to a deleteri- 
ous effect on cell viability resulting  from prolonged cyclo- 
heximide treatment,  since there was usually no more than a 
5-10% decline in the number of cells scored as positive for 
the presence of adhesion plaques during the second incuba- 
tion (1-4 h) with either PF4, BSA, or fibronectin,  after the 
initial  3-4 h  spreading on fibronectin substrates. 
The Loss of Focal Adhesions Is Induced Specifically 
by TSP 
The observed reduction in focal adhesions  in both cells in 
situ  and in cells  prespread  on fibronectin  was specific for 
TSP. Other platelet proteins, such as PF4 and beta-thrombo- 
globulin, did not affect the number of cells with focal adhe- 
sions even when tested at molar concentrations nearly  15x 
higher than those effective for TSP (Fig. 4 and Table liD. Ad- 
dition of fibronectin in solution also did not reduce adhesion 
plaques,  but instead  resulted in slightly enhanced numbers 
of cells with adhesion plaques on fibronectin substrates (Ta- 
ble HI). In addition, the number, distribution, and quality of 
focal adhesion plaques in individual cells were unaffected by 
the presence of PF4 (Fig. 5 c) or beta-thromboglobulin (not 
shown). The localization of vinculin plaques and the distri- 
bution of actin-containing stress fibers in cells treated with 
PF4 were indistinguishable  from those of BSA-treated cells 
(data not shown). 
The Heparin-binding Domain of TSP Is Essential 
for Activity 
When heparin and TSP were co-incubated with BAE cells in 
suspension before se~ling onto fibronectin, the effect of TSP 
on focal adhesion formation was abolished (Table II). Simi- 
larly, heparin neutralized the ability of TSP to reduce focal 
Figure 5.  Interference reflection  microscopy of spread  cells  incu- 
bated with  soluble  TSP. Cells  spread  for 4  h  on fibronectin-ad- 
sorbed coverslips were then incubated for an additional  3 h with (a) 
30 pg BSA, (b) 30 pg TSP, or (c) 30 pg PF4. Experiments were 
performed in the presence of 15 #g/ml cycloheximide.  Interference 
reflection microscopy shows that spread cells incubated  with BSA 
and PF4 have numerous focal adhesion plaques distributed  through- 
out the cytoplasm (arrows);  whereas,  cells  incubated  with  TSP 
which still have focal adhesions have fewer adhesion plaques which 
are predominantly located at the cell  edges (arrowheads). Bars, 
10 #m. 
Murphy-Ullrich and H6~3k 7hrombospondin Effect  on Cytoskeleton  1315 Figure 6.  Distribution of vinculin and F actin in spread cells incubated with soluble TSP. Spread ceils incubated with 30 ~g BSA (a, c, 
and e) or 30 #g TSP (b, d, and f) were double-labeled for vinculin (c and d) or F actin (e and f) as in Fig. 3. Distribution of vinculin 
(c) and actin (e) in cells incubated with BSA is similar to that found in cells incubated with fibronectin for 4 h (Fig. 3). Cells incubated 
with TSP have small vinculin-containing  plaques located at the edges of cells, but rarely in the central region of cells (d). The distribution 
of actin-containing  fibers corresponds to the location of vinculin  plaques: they are primarily located at the cell periphery (f). Phase micro- 
scopic  images of these cells are shown in a  and b. Bars,  10 ~m. 
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Figure 7. Inhibition of TSP-mediated loss of focal 
adhesions by heparin and fucoidan. Cells in situ 
were treated with 30/zg TSP in 500 t~l DME and 
increasing concentrations  of either heparin,  low 
molecular weight  beparin,  fucoidan,  or chon- 
droitin  sulfate. Concentrations  of inhibitors are 
expressed  in  micrograms per  milliliter.  Cells 
were incubated with TSP and inhibitors for 4 h 
in the presence of cyclohexirnide, fixed, and ex- 
amined  by  interference  reflection  microscopy. 
Cells  treated  with  BSA (30  /~g) were used  as 
positive controls and the number of cells with fo- 
cal adhesions in BSA-treated cells (68%) was set 
at 100%. Cells treated with 30/~g TSP alone had 
50% of the number of cells with focal adhesions 
as compared to controls. Results are expressed as 
the percent inhibition in reduction of focal adhe- 
sions  compared  to  cells  incubated  with  TSP 
alone. 
adhesions in cells grown on coverslips in situ (Fig. 7). Low 
molecular weight heparin also neutralized TSP activity, al- 
though somewhat higher concentrations of this form of the 
polysaccharide  were  required.  In addition,  other  sulfated 
polysaccharides,  such as fucoidan and chondroitin  sulfate, 
blocked TSP activity. Fucoidan was effective at concentra- 
tions comparable to the heparins, whereas, at least 500-fold 
(wt/wt) more chondroitin sulfate, as compared to heparin, 
was required to inhibit TSP activity. 
The sensitivity of TSP-mediated focal adhesion reduction 
to sulfated polysaccharides, such as heparin and fucoidan, 
suggests that the heparin-binding domain of TSP may be ac- 
tive in focal adhesion reduction. The localization of the ac- 
tive site was further analyzed by examining the  ability of 
three domain-specific monoclonal antibodies  to neutralize 
TSP activity. The active site appears to reside in the heparin- 
binding  domain,  since  antibody  A2.5,  which  is  directed 
Table IV. Inhibition of TSP-mediated Reduction of  Focal 
Adhesions by Domain-specific Monoclonal Antibodies 
Percent control 
TSP (30 tzg)  45 
BSA (30 #g)  100 
TSP  +  mAb A2.5  (10/~g) 
TSP  +  mAb A6.1  (10 ftg) 
TSP  +  mAb C6.7  (10 btg) 
TSP  +  NS1  (ascites control) 
90 
44 
56 
56 
mAb A2.5  (10/~g)  97 
mAb A6.1  (10 #g)  70 
rnAb C6.7  (10/zg)  83 
NSI  98 
mAb  A2.5  reacts  with  the  NH2-terminal  heparin-binding domain of TSP; 
A6.1  reacts  with  the  core-region;  C6.7  reacts  with  the  COOH-terminal 
platelet-binding domain. NSI  is normal mouse ascites. The antibodies were 
added together with TSP to prespread cells and incubated for 3 h. In BSA-treated 
controls, 71% of the cells formed focal adhesion plaques. Similar results were 
obtained using cells grown on coverslips and tested in situ. 
against the amino-terminal heparin-binding domain of TSP, 
completely blocked the effect of TSP when tested at 10/zg/ml 
protein,  whereas,  monoclonal  antibodies  C6.7  and  A6.1 
directed against epitol~s in the carboxy-terminal and core 
domains of TSP, respectively, did not prevent TSP-mediated 
focal adhesion loss (Table IV).  Antibodies A2.5  and C6.7 
tested alone had no significant effect on focal adhesion stabil- 
ity,  however,  antibody  A6.1 did  cause  a  slight  reduction 
(30%)  in focal adhesion positive cells. 
TSP Interactions with Heparan Sulfate Appear to be 
Significant for TSP Activity 
Previous studies have demonstrated that TSP binds to hepa- 
ran sulfate located at the surface of Chinese hamster ovary, 
melanoma, mammary epithelial, and BAE cells (35, 36, 41, 
46).  It is therefore possible that the effect of TSP on focal 
adhesion formation and reduction is exerted via an interac- 
tion of the protein with heparan sulfate. Two other heparin- 
binding proteins, PF4 and beta-thromboglobulin, were tested 
for their  ability  to  neutralize  TSP-mediated  loss  of focal 
adhesions.  These  molecules compete for TSP binding  to 
BAE cells (35). PF4 binds to heparan sulfate on endothelial 
cells and it has recently been shown that TSP and PF,4 may 
interact with a common subspecies of heparan sulfate (4, 41). 
When  tested in cells in  situ,  both proteins  neutralized  the 
ability of TSP to cause reduction of focal adhesion positive 
cells. PF4 (10 #g) blocked 100% and beta-thromboglobulin 
(10 #g) blocked 77 % of TSP activity. These data, in concert 
with the fact that sulfated polysaccharides neutralize TSP ac- 
tivity, suggest that interactions of TSP with heparan sulfate 
are required to cause TSP-mediated reduction of focal adhe- 
sions. 
Discussion 
These studies show that TSP can serve as a substrate for en- 
dothelial  cell  attachment,  but  that  TSP substmtes are  not 
competent to mediate cell spreading and focal adhesion for- 
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observed for adhesion processes mediated by cell-associated 
heparan sulfate prote,  oglycans (21, 22).  In fact, cell attach- 
ment to TSP substrates can be blocked by the addition of hep- 
arin, and cells deficient in heparan sulfate proteoglycans do 
not attach to TSP substrates (18). TSP-integrin interactions 
also support initial cell attachment (25),  however,  interac- 
tions of TSP with these receptors on endothelial cells do not 
appear to be sufficient to mediate the later stages of the com- 
plete cell adhesion process, cell spreading, and focal adhe- 
sion formation. This is consistent with the observations of 
Lawler et al.  (25),  who reported that endothelial cells at- 
tached to TSP substrates did not undergo spreading. 
Not only do TSP substrates fail to promote physiologic 
adhesion, but soluble TSP either preincubated with cells be- 
fore attachment or added to cells at the time of seeding pre- 
vents the formation of focal adhesion plaques. Furthermore, 
we show that soluble TSP added to adherent, fully spread 
cells, either in situ or on fibronectin substrates,  causes a 
reduction in the number of cells with focal adhesion plaques 
without significantly affecting cell spreading. 
The effect of TSP was not limited to BAE cells, since we 
observed a similar reduction in the number of cells with focal 
adhesions in experiments using human embryo fibroblasts 
(data not shown). 
It is not known what molecular mechanisms are involved 
in TSP-mediated inhibition of focal adhesion formation and 
in focal adhesion disassembly. We cannot exclude the possi- 
bility that the loss of focal adhesions in prespread cells is due 
to TSP inhibition of re-formation of focal adhesions, rather 
than to the effect of TSP inducing disassembly of formed fo- 
cal adhesions. In these experiments, the ability of TSP to ei- 
ther prevent focal adhesion formation or to cause a reduction 
in focal adhesions was only partial. This may reflect hetero- 
geneity within a  population of cells with respect to TSP- 
binding and degradation (see Fig. 6 in reference 36), as well 
as, heterogeneity in focal adhesion stability and turnover. 
In this study, the active site has been located to the heparin- 
binding domain of TSP and binding to cell-associated hepa- 
ran sulfate seems to be an important step  in the inhibitory 
and/or reductive process, since the presence of sulfated poly- 
saccharides and other  heparin-binding proteins,  PF4  and 
beta-thromboglobulin, interfere with the action of TSP. It is 
reasonable that PF4 neutralizes TSP activity by competing 
for cell-associated heparan sulfate, since it has recently been 
reported that TSP and PF4 bind to overlapping populations 
of heparan sulfate molecules from melanoma cells (41). The 
formation of  focal adhesions by fibroblasts and Chinese ham- 
ster ovary cells has been shown to be dependent upon a dual 
receptor-ligand interaction, involving a receptor of the inte- 
grin type and a cell-associated heparan sulfate proteoglycan 
(26,  52).  It is therefore not surprising that blocking of the 
heparan  sulfate proteoglycan with a  soluble ligand  (e.g., 
TSP) may interfere with the process of focal adhesion forma- 
tion and reduction.  However,  binding of a  ligand to cell- 
associated heparan sulfate does not automatically lead to loss 
of focal adhesions, since addition of PF4 and beta-thrombo- 
globulin to fully spread adherent cells did not result in a 
reduction of focal adhesion plaques. Therefore, there appear 
to be properties of TSP, distinct from its heparin-binding ac- 
tivity, that are active in preventing focal adhesion formation 
and causing loss of focal adhesions. It is possible that a sec- 
ond site on the TSP molecule is mechanistically important. 
The assays in which addition of TSP caused focal adhesion 
loss in cells in situ show that the TSP effect on focal ad- 
hesions is not simply due to selective trypsin sensitivity of 
various matrix receptors which may potentially be cleaved 
during cell harvesting before seeding onto fibronectin sub- 
strates.  Furthermore, these data show that TSP is active on 
cells spread on their native matrices. 
TSP appears to preferentially affect adhesion plaques lo- 
cated in the central regions of the cells: plaques at the cell 
periphery are refractory to the presence of TSE at least dur- 
ing the course of these experiments. The significance of this 
observation is not clear, however, there may be heterogeneity 
in the temporal stability, structure, or regulation of adhesion 
plaque formation/disassembly between focal adhesions lo- 
cated in various parts of the cell. There is some evidence for 
such heterogeneity: Dejana et al.  (8)  recently showed that 
endothelial cells spread on vitronectin initially (within 30 
min) formed plaques only at the cell edges, and later, adhe- 
sion plaques also appeared in the central regions of the cell. 
It has also been shown that transformed cells have "dot'-type 
focal adhesions at the cell edges, whereas their nontrans- 
formed counterparts have focal adhesions in both the central 
and peripheral regions of cells (1, 31). 
The data presented in this report suggest that TSP destabi- 
lizes cell matrix contacts. This function may correspond to 
the apparent temporal availability of TSP in tissues. TSP is 
released  in large amounts from platelets after injury and 
platelet aggregation. Transcription of TSP mRNA and syn- 
thesis of TSP are increased rapidly, although transiently, in 
the presence of growth factors (29, 30, 37). It is also a tran- 
sient component of clot matrices (33) and is present during 
the early stages of wound healing (38). Similarly, the binding 
of TSP is increased in subconfluent as compared to density- 
arrested cells (34). The interaction of TSP with cells is short 
lived, as it is rapidly degraded by the cells (28, 34-36). Thus, 
based on these data, it is reasonable to suggest that TSP func- 
tions in processes such as wound healing, angiogenesis, and 
development by "priming" cells for mitosis or migration by 
destabilizing cell matrix contacts through the loss of focal 
adhesion plaques. 
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